Antonio Llombart-Cussac

22PUBLICATIONS
168CO-AUTHORS
Predictive and prognostic markersInnate immunityGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples theory of change models for health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Oct 13, 2026
Cerebrospinal fluid and plasma circulating tumor DNA dynamics as a biomarker of response during trastuzumab deruxtecan treatment in patients with breast cancer with leptomeningeal disease.

|Sep 16, 2026
Impact of Prior Exposure to Anisakis simplex Antigens on Immune Response During SARS-CoV-2 Vaccination.

|Jul 28, 2026
SARS-CoV-2 mRNA Vaccination Induces Reduced T-Cell Apoptosis in Patients with Solid Tumors.

|Jul 09, 2026
Modulation of the response to immunotherapy in triple-negative breast cancer: the role of the microbiota and microbial metabolites in the tumor microenvironment.

|Dec 17, 2025
KEYLYNK-009: Pembrolizumab plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer after Clinical Benefit from First-Line Pembrolizumab plus Chemotherapy.

Hope S Rugo, David W Cescon, Mark E Robson

|Sep 27, 2025
Immunogenicity of SARS-CoV-2 mRNA Vaccine in Breast Cancer Patients Undergoing Active Treatment: A Prospective Observational Study.

María Leonor Fernández-Murga, Lucía Serrano-García, Giuseppe D'Auria

Pageof 4

Frequent Collaborators

9 joint publications

Javier Cortes

6 joint publications

María Leonor Fernández-Murga

5 joint publications

Manuel Ruiz-Borrego

3 joint publications

Jose Pérez-García